While they sometimes have opposing interests, payers and drug companies can work together so that patients have better access to new, innovative medications, according to a Health Affairs Blog post.
Sometimes one simple answer a question can prove as compelling and relevant as an 800-word commentary, a 15-minute video interview or a six-panelist, one-hour workshop session. Case in point, a recent Forbes report in which doctors were asked how many patients had inquired about integrating data from a fitness mHealth device into their electronic patient record. As this week's article on this polling exercise points out, not too many are at all interested in connecting healthcare data activities. As the doctors indicate, more than a good majority of patients--85 percent--haven't asked the question.
Pharamceutical companies should implement "beyond-the-pill" strategies that move past their traditional business model and work with payers in new ways to meet the challenges facing the healthcare industry.
Apple's long-rumored smartwatch may be subsidized by health insurers, according to a note to investors from Cowen & Company obtained by Investor's Business Daily.
While the future success of the mobile healthcare industry hinges primarily on adoption and acceptance of technology among providers and consumers, the role of payers is growing increasingly important, as well. With that in mind, insurance companies need to approach diving into mHealth very carefully, according to Paul Nutting, divisional vice president of customer experience with Chicago-based Health Care Service Corporation, and Anoop Bhogal, director, information services and relationship management at Philadelphia-based Independence Blue Cross.
Healthcare organizations are forging ahead with mobile health initiatives, but they don't necessarily have a clear game plan for the programs, a recent study finds.